Taiwan has given emergency use authorization (EUA) to a COVID-19 vaccine developed by Taiwan-based Medigen Vaccine Biologics Corp. after a panel of experts felt its data on the vaccine's production of antibodies in Phase 2 trials met local standards.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares close up 0.81%
12/02/2025 01:59 PM - Society
Taipei recycling worker gets suspended sentence in rice cooker case
12/02/2025 01:44 PM - Business
Terry Gou's daughter to dispose of all Hon Hai shares she owns
12/02/2025 01:20 PM - Science & Tech
Study links infant formula feeding to higher child obesity risk
12/02/2025 01:00 PM - Society
Cooler air expected later this week: CWA
12/02/2025 11:13 AM